Bausch & Lomb rounds out lens family
This article was originally published in The Gray Sheet
Executive Summary
With the launch of its PureVision multi-focal contact lens for vision correction in people with presbyopia, announced Feb. 23, Bausch & Lomb offers a full range of silicone hydrogel lenses, which also includes PureVision spherical and PureVision toric designs, according to the company. The multi-focal lens, which is uniquely indicated for daily wear or for extended wear up to 30 days, is the first of its type to reach the U.S. market, the firm says. Though the multi-focal lens was approved by FDA last spring, roll-out has been delayed while the company worked to increase its manufacturing capacity (1"The Gray Sheet" Dec. 5, 2005, p. 8)...
You may also be interested in...
Bausch & Lomb To Compete In Silicone Hydrogel Lens Market With PureVision
Bausch & Lomb predicts that a recent increase in manufacturing capacity will allow its PureVision SVS line of silicone hydrogel contact lenses to take market share from Ciba Vision and Johnson & Johnson/Vistakon
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.